RESEARCH-USE BIOSIMILAR ANTIBODY
Sotevtamab
Monoclonal antibody · IgG2
Sotevtamab (16B5) is a humanized IgG2 anti-clusterin monoclonal antibody (mAb). Sotevtamab is an inhibitor of the epithelial to mesenchymal transition. Sotevtamab can be used for cancer research.
TARGETCLU
YMonoclonal antibody
CATALOGSC-BS-159
CATALOG NUMBERSC-BS-159
MOLECULAR WEIGHTApprox. 146.2 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Sotevtamab (16B5) is a humanized IgG2 anti-clusterin monoclonal antibody (mAb). Sotevtamab is an inhibitor of the epithelial to mesenchymal transition. Sotevtamab can be used for cancer research.
Sotevtamab is a recombinant research-use antibody directed against CLU.